Skip to main content
placeholder image

Efficacy, Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine in Adults Aged 60 Years and Older: Results From the ZOE-50 and ZOE-70 Efficacy Studies

Journal Article


Abstract


Publication Date


  • 2016

Citation


  • McElhaney, J. E., Lal, H., Cunningham, A. L., Levin, M. J., Chlibek, R., Diez-Domingo, J., . . . Heineman, T. C. (2016). Efficacy, Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine in Adults Aged 60 Years and Older: Results From the ZOE-50 and ZOE-70 Efficacy Studies. Open Forum Infectious Diseases, 3(suppl_1), 127. doi:10.1093/ofid/ofw194.40

Web Of Science Accession Number


Start Page


  • 127

Volume


  • 3

Issue


  • suppl_1

Abstract


Publication Date


  • 2016

Citation


  • McElhaney, J. E., Lal, H., Cunningham, A. L., Levin, M. J., Chlibek, R., Diez-Domingo, J., . . . Heineman, T. C. (2016). Efficacy, Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine in Adults Aged 60 Years and Older: Results From the ZOE-50 and ZOE-70 Efficacy Studies. Open Forum Infectious Diseases, 3(suppl_1), 127. doi:10.1093/ofid/ofw194.40

Web Of Science Accession Number


Start Page


  • 127

Volume


  • 3

Issue


  • suppl_1